Answers are grounded in this paper and cite their sources.
Dual-acting AC medications exhibit a high degree of overall effectiveness and are well tolerated for chronic use. A newly available once-daily medication that manages signs and symptoms of AC for a full 24 hours may be considered a treatment of choice for patients experiencing seasonal or perennial AC. ClinicalTrials.gov NCT01743027 and NCT01479374.
No takes yet. Share an insight, caveat, or question.
Carr et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: